Precigen (PGEN) Deferred Taxes (2015 - 2024)
Precigen (PGEN) reported Deferred Taxes of -$89000.0 for Q4 2024, up 74.79% year-over-year from -$50919.0 in Q1 2024, and down 841.67% quarter-over-quarter from $12000.0 in Q3 2024.
Precigen (PGEN) Deferred Taxes (2015 - 2024) Analysis & Trends
Precigen (PGEN) has 10 years of Deferred Taxes data on file, last reported at -$89000.0 in Q4 2024.
- Deferred Taxes for Q4 2024 came in at -$89000.0, up 74.79% year-over-year; the trailing twelve-month figure through Sep 2025 was -$89000.0 (up 95.68% YoY), and the FY2024 annual result was -$1.8 million, down 274.74% from the prior year.
- Deferred Taxes eased to -$89000.0 in Q4 2024 per PGEN's latest filing, from $12000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $48000.0 in Q4 2020 and troughed at -$1.7 million in Q2 2024.
- A 5-year average of -$144578.9 and a median of -$56000.0 in 2021 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2023 and 2024: Deferred Taxes slumped 3041.67% in 2023, then surged 192.31% in 2024.
- A 5-year view of Deferred Taxes shows it stood at $48000.0 in 2020, then slumped by 72.92% to $13000.0 in 2021, then decreased by 7.69% to $12000.0 in 2022, then tumbled by 3041.67% to -$353000.0 in 2023, then surged by 74.79% to -$89000.0 in 2024.
- Business Quant data shows PGEN's Deferred Taxes at -$89000.0 in Q4 2024, $12000.0 in Q3 2024, and -$1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -353,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -58,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -63,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -68,000.00 |
| Jun 30, 2020 | -136,000.00 |
| Dec 31, 2019 | -2.23 Mn |